Abstract:In this study, we conducted a targeted siRNA screening and identified TATA box‐binding protein‐associated factor, TAF1D, as a critical regulator of the cell cycle and proliferation in high‐risk neuroblastoma cells in vivo and in vitro. Mechanistically, we demonstrate that TAF1D knockdown downregulates the expression of a set of G2/M phase‐related genes, including the master cell cycle kinase, cyclin‐dependent kinase 1 (CDK1), and leads to G2/M arrest. Thus, our work describes a novel cell‐cycle regulatory function of TAF1D in MYCN‐amplified HR‐NB that warrants further investigation as a potential therapeutic target and biomarker for high‐risk neuroblastoma. High‐risk neuroblastoma (HR‐NB) is an aggressive childhood cancer that responds poorly to currently available therapies and is associated with only about a 50% 5‐year survival rate. MYCN amplification is a critical driver of these aggressive tumors, but so far there have not been any approved treatments to effectively treat HR‐NB by targeting MYCN or its downstream effectors. Thus, the identification of novel molecular targets and therapeutic strategies to treat children diagnosed with HR‐NB represents an urgent unmet medical need. Here, we conducted a targeted siRNA screening and identified TATA box‐binding protein‐associated factor RNA polymerase I subunit D, TAF1D, as a critical regulator of the cell cycle and proliferation in HR‐NB cells. Analysis of three independent primary NB cohorts determined that high TAF1D expression correlated with MYCN‐amplified, high‐risk disease and poor clinical outcomes. TAF1D knockdown more robustly inhibited cell proliferation in MYCN‐amplified NB cells compared with MYCN‐non‐amplified NB cells, as well as suppressed colony formation and inhibited tumor growth in a xenograft mouse model of MYCN‐amplified NB. RNA‐seq analysis revealed that TAF1D knockdown downregulates the expression of genes associated with the G2/M transition, including the master cell‐cycle regulator, cell‐cycle‐dependent kinase 1 (CDK1), resulting in cell‐cycle arrest at G2/M. Our findings demonstrate that TAF1D is a key oncogenic regulator of MYCN‐amplified HR‐NB and suggest that therapeutic targeting of TAF1D may be a viable strategy to treat HR‐NB patients by blocking cell‐cycle progression and the proliferation of tumor cells.

Transcriptional Co-Activator TAZ Sustains Proliferation and Tumorigenicity of Neuroblastoma by Targeting CTGF and PDGF-β

Transcriptional Co-Activator with PDZ-binding Motif Overexpression Promotes Cell Proliferation and Transcriptional Co-Activator with PDZ-binding Motif Deficiency Induces Cell Cycle Arrest in Neuroblastoma.

Yap Promotes The Proliferation Of Neuroblastoma Cells Through Decreasing The Nuclear Location Of P27(Kip1) Mediated By Akt

Collaborative ISL1/GATA3 interaction in controlling neuroblastoma oncogenic pathways overlapping with but distinct from MYCN.

TAF1D promotes proliferation by transcriptionally activating G2/M phase‐related genes in MYCN‐amplified neuroblastoma

TTF1 Suppresses Neuroblastoma Growth and Induces Neuroblastoma Differentiation by Targeting TrkA and the Mir-204/Trkb Axis

The Hippo transducer TAZ promotes cell proliferation and tumor formation of glioblastoma cells through EGFR pathway

Knockdown of TAZ Modifies Triple-Negative Breast Cancer Cell Sensitivity to EGFR Inhibitors by Regulating YAP Expression.

A positive feedback loop between TAZ and miR-942-3p modulates proliferation, angiogenesis, epithelial-mesenchymal transition process, glycometabolism and ROS homeostasis in human bladder cancer

Tead Transcription Factors Mediate the Function of Taz in Cell Growth and Epithelial-Mesenchymal Transition

Smoothened-Independent Activation of Hedgehog Signaling by Rearranged During Transfection Promotes Neuroblastoma Cell Proliferation and Tumor Growth

NEAT1 Negatively Regulates Cell Proliferation and Migration of Neuroblastoma Cells by Mir-183-5p/foxp1 Via the ERK/AKT Pathway.

Epigenetic Targeting of TERT-Associated Gene Expression Signature in Human Neuroblastoma with TERT Overexpression

Regulation of Neuroblastoma Differentiation by Forkhead Transcription Factors FOXO1/3/4 Through the Receptor Tyrosine Kinase PDGFRA

PEST-containing Nuclear Protein Mediates the Proliferation, Migration, and Invasion of Human Neuroblastoma Cells Through MAPK and PI3K/AKT/mTOR Signaling Pathways.

Activated Beta-Catenin Forces N2a Cell-Derived Neurons Back To Tumor-Like Neuroblasts And Positively Correlates With A Risk For Human Neuroblastoma

Truncated TEAD-binding Protein of TAZ Inhibits Glioma Survival Through the Induction of Apoptosis and Repression of Epithelial-Mesenchymal Transition.

PRMT1 Promotes Neuroblastoma Cell Survival Through ATF5.

Therapeutic Targeting of YY1/MZF1 Axis by MZF1-uPEP Inhibits Aerobic Glycolysis and Neuroblastoma Progression

MiR-542-3p suppresses neuroblastoma cell proliferation and invasion by downregulation of KDM1A and ZNF346

The Increased IL-17-producing Γδt Cells Promote Tumor Cell Proliferation and Migration in Neuroblastoma.